Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE 7 ACWAS: Delayed vs Early Cardioversion for Acute Atrial Fibrillation
NCT02248753Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2014
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of metoprolol, verapamil and digoxin in Atrial fibrillation (AFib) (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Presence of sinus rhythm on 12-lead ECG at 4 weeks. Started Oct 2014; status: completed.
02
Drugs
metoprololverapamildigoxin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02248753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248753.